Al Razi profit drops 66% to SAR 686,000 in 2023

30/03/2024 Argaam Exclusive

Al Razi Medical Co. reported a 66% fall in 2023 net profit to SAR 686,000, from SAR 2 million a year earlier.



Financials (M)

Item 2022 2023 Change‬
Revenues 52.39 61.33 17.1 %
Gross Income 16.10 17.58 9.2 %
Operating Income 2.59 1.41 (45.4 %)
Net Income 2.01 0.69 (65.9 %)
Average Shares 1.52 1.52 -
EPS (Riyals) 1.33 0.45 (65.9 %)

The profit decline was due to the company's investment in promotions to support sales of non-pharmaceutical products on the website and branches, as well as the higher selling and distribution expenses of new branches that are in the process of growing to achieve the sales target.

 

However, revenues rose by 17.1% year-on-year (YoY), or SAR 8.9 million, driven by the increase in sales from pharmacy branches opened in late 2022 and 2023.



Current Half Annual Comparison (M)

Compared With The
Item H2 2022 H2 2023 Change‬
Revenues 28.32 30.79 8.7 %
Gross Income 9.01 8.43 (6.3 %)
Operating Income 1.82 0.42 (77.2 %)
Net Income 1.43 0.08 (94.5 %)
Average Shares 1.52 1.52 -
EPS (Riyals) 0.94 0.05 (94.5 %)

Total shareholders’ equity, no minority interest, reached SAR 22.4 million as of Dec. 31, 2023, from SAR 23.6 million a year earlier.

 

Historical Data

Period

Revenues (SAR mln)

Net Profit (SAR mln)

EPS (SAR)

H1 2022

24.07

0.58

0.38

H2 2022

28.32

1.43

0.94

H1 2023

30.54

0.61

0.40

H2 2023

30.79

0.08

0.05

 

View more financial results

 

View other reports

Share Price

Al-Razi Medical Co.
53.00
3.00 6.00 %

Al-Razi Medical Co. (ALRAZI)

More


Financial Ratios
Current
Market Cap (M Riyal) 80.56
Enterprise Value (EV) (M) 82.57
Shares Outstanding ((M)) 1.52
Book Value (BV) ( Riyal) 14.72
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) More than 100
Price/book 3.60
more

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2024, Argaam Investment, All Rights Reserved
Call Request